Vascular Disease Management

Abstract

We report on our center’s clinical experience which supports the view that the new TIF Pinnacle sheath offers superior performance and enhanced safety. The complication rate was essentially nil and the use of closure devices was obviated altogether. However, these conclusions should be tempered by the limited nature of the study, mainly, the absence of a control patient subset, the potential built-in bias related to case selection and observation of outcomes, and its small size.

VASCULAR DISEASE MANAGEMENT 2010;7:E168–E170

Abstract

Spontaneous upper limb deep venous thrombosis (DVT) is associated with exercise and occurs in young healthy individuals. Underlying anatomical abnormalities are often found, causing compression of the subclavian vein. Prompt thrombolysis and consideration of thoracic outlet decompression differentiate it from lower limb DVT. A case illustrating the clinical features of the condition is presented here.

VASCULAR DISEASE MANAGEMENT 2010;7:E175–E177

Key words: Paget-Schröetter syndrome; deep venous thrombosis; exe

VASCULAR DISEASE MANAGEMENT 2010;7:E179–E180

_______________________________________________

What is the purpose and scope of the RESTORE- CLI trial? How many patients and centers will be involved in the Phase 3 trial, and when will it be completed?

This study is designed to evaluate the safety and efficacy of autologous tissue repair cells (TRCs) for patients with peripheral arterial disease as a treatment for critical limb ischemia (CLI). RESTORE-CLI is a Phase 2b study and will complete patient follow-up in March of 20